Probiotics as Antifungals in Mucosal Candidiasis.

Probiotics as Antifungals in Mucosal Candidiasis.

Item
http://www.wikidata.org/entity/Q38716578
Probiotic Lactobacillus reuteri has antifungal effects on oral Candida species in vitro.Antimicrobial Compounds Produced by Vaginal Lactobacillus crispatus Are Able to Strongly Inhibit Candida albicans Growth, Hyphal Formation and Regulate Virulence-related Gene Expressions.Future therapies targeted towards eliminating Candida biofilms and associated infections.Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation.Early gut mycobiota and mother-offspring transfer.Probiotic Bacteria Alter Pattern-Recognition Receptor Expression and Cytokine Profile in a Human Macrophage Model Challenged with Candida albicans and Lipopolysaccharide.Fungal interactions with the human host: exploring the spectrum of symbiosis.Clinical strains of Lactobacillus reduce the filamentation of Candida albicans and protect Galleria mellonella against experimental candidiasis.Lactobacillus is able to alter the virulence and the sensitivity profile of Candida albicans.Probiotics: A Promising Role in Dental Health.
P2860

Probiotics as Antifungals in Mucosal Candidiasis.

Item
http://www.wikidata.org/entity/Q38716578
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Probiotics as Antifungals in Mucosal Candidiasis.
@en
type
label
Probiotics as Antifungals in Mucosal Candidiasis.
@en
prefLabel
Probiotics as Antifungals in Mucosal Candidiasis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Probiotics as Antifungals in Mucosal Candidiasis
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921